Shopping Cart 0
Cart Subtotal
AED 0

Boston Children's Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Boston Children's Hospital (Boston Children's) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children's is the primary pediatric teaching affiliate of Harvard Medical School. The organization provides specialty services such as cardiovascular surgery, digestive care, blood diseases, fetal care and others. Its Advanced Fetal Care Center supports the needs of families and referring physicians at all steps of care for various congenital anomalies, from diagnosis and counseling through treatment and follow-up. It also collaborates with other institutes such as Harvard Stem Cell Institute, MIT Health Sciences & Technology, the Broad Institute, the Autism Consortium and Boston University. Boston Children's is headquartered in Boston, Massachusetts, the US.

Boston Children's Hospital-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Boston Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

ClearPath Vaccines and Astellas Pharma Enter into Research Agreement with Boston Children's Hospital 13

Amgen Enters into Research Agreement with Boston Children's Hospital 14

Boston Children's Hospital Enters into Agreement with GE Healthcare 15

Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 16

Gruenenthal, Proteus and Boston Children's Hospital Enter into Agreement 18

Grunenthal Enters into Agreement with Proteus and Boston Children's Hospital 19

Fate Therapeutics Enters into Research Agreement with Boston Children's Hospital 20

Boston Children's Hospital Enters Into Co-Development Agreement With Abwiz Bio 21

Shire Enters Into Co-Development Agreement With Boston Children's Hospital For Pediatric Therapies 22

Life Technologies Enters Into Co-Development Agreement With Boston Children's Hospital 23

Merger 24

Warren Hospital Merges With St. Luke's Hospital 24

Licensing Agreements 25

Consortia TX Enters into Licensing Agreement with Brigham and Women's Hospital (BWH) and Boston Children's Hospital 25

Cambridge Epigenetix Enters into Licensing Agreement with Boston Children's Hospital 26

Affinivax Enters into Licensing Agreement with Boston Children's Hospital for MAPS Technology 27

Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 28

Boston Children's Hospital-Key Competitors 29

Boston Children's Hospital-Key Employees 30

Boston Children's Hospital-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Joint Venture 36

Recent Developments 37

Strategy And Business Planning 37

May 01, 2017: Boston Orthotics & Prosthetics Adds a Second Clinic in Waltham, MA 37

Government and Public Interest 38

Oct 10, 2018: Columbia scientist Anthony Fitzpatrick and collaborators awarded USD 7.8M to identify new targets against brain disease 38

Oct 09, 2018: Earlier treatment may help reverse autism-like behavior in tuberous sclerosis 39

Sep 24, 2018: Mount Sinai researchers receive USD 43 million grant to study impact of environmental exposures on children's health and development 41

May 11, 2018: Trial shows chemotherapy is helping kids live with pulmonary vein stenosis 42

Apr 04, 2018: A new tactic for antibiotic-resistant pneumonia: Making neutrophils stronger, but fewer in number 44

Apr 02, 2018: Two-drug approach halts lung tumors by starving them metabolically 45

Jan 25, 2018: Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma 47

Jan 10, 2018: Robotic implants spur tissue regeneration inside the body 49

Dec 06, 2017: Routing gene therapy directly into the brain 50

Nov 07, 2017: Boston Children's Hospital Receives Grant to Support Malaria Research and Music Therapy Program Honoring Dr. Gary Loveman 52

Aug 14, 2017: Breakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice 53

Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 54

May 12, 2017: Researchers find key molecule that could lead to new therapies for anemia 56

Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 58

Product News 59

Jul 17, 2018: Skewed T-cell pathway may help explain transplant rejection, autoimmune diseases 59

Jan 31, 2018: Sickle cell gene therapy to boost fetal hemoglobin: A 70-year timeline of discovery 62

Other Significant Developments 63

Jan 15, 2018: Multidisciplinary care to treat severe asthma 63

Dec 13, 2017: Care.com and AARP Announce the Launch of the Care Institute to Support the Nation's Care Workforce and Meet the Rising Demand for Care 64

Appendix 65

Methodology 65

About GlobalData 65

Contact Us 65

Disclaimer 65


List Of Figure

List of Figures

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Boston Children's Hospital, Pharmaceuticals & Healthcare, Key Facts 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Boston Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Boston Children's Hospital, Deals By Therapy Area, 2012 to YTD 2018 9

Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

ClearPath Vaccines and Astellas Pharma Enter into Research Agreement with Boston Children's Hospital 13

Amgen Enters into Research Agreement with Boston Children's Hospital 14

Boston Children's Hospital Enters into Agreement with GE Healthcare 15

Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 16

Gruenenthal, Proteus and Boston Children's Hospital Enter into Agreement 18

Grunenthal Enters into Agreement with Proteus and Boston Children's Hospital 19

Fate Therapeutics Enters into Research Agreement with Boston Children's Hospital 20

Boston Children's Hospital Enters Into Co-Development Agreement With Abwiz Bio 21

Shire Enters Into Co-Development Agreement With Boston Children's Hospital For Pediatric Therapies 22

Life Technologies Enters Into Co-Development Agreement With Boston Children's Hospital 23

Warren Hospital Merges With St. Luke's Hospital 24

Consortia TX Enters into Licensing Agreement with Brigham and Women's Hospital (BWH) and Boston Children's Hospital 25

Cambridge Epigenetix Enters into Licensing Agreement with Boston Children's Hospital 26

Affinivax Enters into Licensing Agreement with Boston Children's Hospital for MAPS Technology 27

Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 28

Boston Children's Hospital, Key Competitors 29

Boston Children's Hospital, Key Employees 30

Boston Children's Hospital, Key Employees (cont..) 33

Boston Children's Hospital, Other Locations 35

Boston Children's Hospital, Subsidiaries 36

Boston Children's Hospital, Joint Venture 36

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Boston Children's Hospital (Boston Children's) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children's is the primary pediatric teaching affiliate of Harvard Medical School. The organization provides specialty services such as cardiovascular surgery, digestive care, blood diseases, fetal care and others. Its Advanced Fetal Care Center supports the needs of families and referring physicians at all steps of care for various congenital anomalies, from diagnosis and counseling through treatment and follow-up. It also collaborates with other institutes such as Harvard Stem Cell Institute, MIT Health Sciences & Technology, the Broad Institute, the Autism Consortium and Boston University. Boston Children's is headquartered in Boston, Massachusetts, the US.

Boston Children's Hospital-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Boston Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

ClearPath Vaccines and Astellas Pharma Enter into Research Agreement with Boston Children's Hospital 13

Amgen Enters into Research Agreement with Boston Children's Hospital 14

Boston Children's Hospital Enters into Agreement with GE Healthcare 15

Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 16

Gruenenthal, Proteus and Boston Children's Hospital Enter into Agreement 18

Grunenthal Enters into Agreement with Proteus and Boston Children's Hospital 19

Fate Therapeutics Enters into Research Agreement with Boston Children's Hospital 20

Boston Children's Hospital Enters Into Co-Development Agreement With Abwiz Bio 21

Shire Enters Into Co-Development Agreement With Boston Children's Hospital For Pediatric Therapies 22

Life Technologies Enters Into Co-Development Agreement With Boston Children's Hospital 23

Merger 24

Warren Hospital Merges With St. Luke's Hospital 24

Licensing Agreements 25

Consortia TX Enters into Licensing Agreement with Brigham and Women's Hospital (BWH) and Boston Children's Hospital 25

Cambridge Epigenetix Enters into Licensing Agreement with Boston Children's Hospital 26

Affinivax Enters into Licensing Agreement with Boston Children's Hospital for MAPS Technology 27

Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 28

Boston Children's Hospital-Key Competitors 29

Boston Children's Hospital-Key Employees 30

Boston Children's Hospital-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Joint Venture 36

Recent Developments 37

Strategy And Business Planning 37

May 01, 2017: Boston Orthotics & Prosthetics Adds a Second Clinic in Waltham, MA 37

Government and Public Interest 38

Oct 10, 2018: Columbia scientist Anthony Fitzpatrick and collaborators awarded USD 7.8M to identify new targets against brain disease 38

Oct 09, 2018: Earlier treatment may help reverse autism-like behavior in tuberous sclerosis 39

Sep 24, 2018: Mount Sinai researchers receive USD 43 million grant to study impact of environmental exposures on children's health and development 41

May 11, 2018: Trial shows chemotherapy is helping kids live with pulmonary vein stenosis 42

Apr 04, 2018: A new tactic for antibiotic-resistant pneumonia: Making neutrophils stronger, but fewer in number 44

Apr 02, 2018: Two-drug approach halts lung tumors by starving them metabolically 45

Jan 25, 2018: Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma 47

Jan 10, 2018: Robotic implants spur tissue regeneration inside the body 49

Dec 06, 2017: Routing gene therapy directly into the brain 50

Nov 07, 2017: Boston Children's Hospital Receives Grant to Support Malaria Research and Music Therapy Program Honoring Dr. Gary Loveman 52

Aug 14, 2017: Breakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice 53

Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 54

May 12, 2017: Researchers find key molecule that could lead to new therapies for anemia 56

Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 58

Product News 59

Jul 17, 2018: Skewed T-cell pathway may help explain transplant rejection, autoimmune diseases 59

Jan 31, 2018: Sickle cell gene therapy to boost fetal hemoglobin: A 70-year timeline of discovery 62

Other Significant Developments 63

Jan 15, 2018: Multidisciplinary care to treat severe asthma 63

Dec 13, 2017: Care.com and AARP Announce the Launch of the Care Institute to Support the Nation's Care Workforce and Meet the Rising Demand for Care 64

Appendix 65

Methodology 65

About GlobalData 65

Contact Us 65

Disclaimer 65


List Of Figure

List of Figures

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Boston Children's Hospital, Pharmaceuticals & Healthcare, Key Facts 2

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Boston Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Boston Children's Hospital, Deals By Therapy Area, 2012 to YTD 2018 9

Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

ClearPath Vaccines and Astellas Pharma Enter into Research Agreement with Boston Children's Hospital 13

Amgen Enters into Research Agreement with Boston Children's Hospital 14

Boston Children's Hospital Enters into Agreement with GE Healthcare 15

Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 16

Gruenenthal, Proteus and Boston Children's Hospital Enter into Agreement 18

Grunenthal Enters into Agreement with Proteus and Boston Children's Hospital 19

Fate Therapeutics Enters into Research Agreement with Boston Children's Hospital 20

Boston Children's Hospital Enters Into Co-Development Agreement With Abwiz Bio 21

Shire Enters Into Co-Development Agreement With Boston Children's Hospital For Pediatric Therapies 22

Life Technologies Enters Into Co-Development Agreement With Boston Children's Hospital 23

Warren Hospital Merges With St. Luke's Hospital 24

Consortia TX Enters into Licensing Agreement with Brigham and Women's Hospital (BWH) and Boston Children's Hospital 25

Cambridge Epigenetix Enters into Licensing Agreement with Boston Children's Hospital 26

Affinivax Enters into Licensing Agreement with Boston Children's Hospital for MAPS Technology 27

Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 28

Boston Children's Hospital, Key Competitors 29

Boston Children's Hospital, Key Employees 30

Boston Children's Hospital, Key Employees (cont..) 33

Boston Children's Hospital, Other Locations 35

Boston Children's Hospital, Subsidiaries 36

Boston Children's Hospital, Joint Venture 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS